FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.14B
AUM Growth
-$232M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$43.7M
2
+$38.3M
3
+$31.7M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$17.5M
5
SVRA icon
Savara
SVRA
+$16.8M

Top Sells

1
+$124M
2
+$52M
3
+$35.6M
4
GPCR icon
Structure Therapeutics
GPCR
+$27M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$22.9M

Sector Composition

1 Healthcare 99.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
– –
-885,165
52
– –
-34,425
53
– –
-85,495
54
– –
-629,194
55
– –
-203,684
56
– –
-1,455,837
57
– –
-3,131,008
1 2
3